

KKR vs CME Group
Major global investment manager for private equity and credit vs Global futures and options exchange operator with clearing services. Which is the better buy for your portfolio in July 2026? Plain-English answer below.
KKR is one of the world's premier alternative asset managers raising and deploying capital across private equity, credit, and real assets at global scale, while CME Group operates the world's largest derivatives exchange and earns fees on every futures and options contract traded. Both firms benefit from financial market complexity and the growing institutional need to manage risk or access alternative returns. The KKR vs CME Group comparison contrasts performance-driven asset management economics with the near-utility-like fee stability of exchange infrastructure.
KKR is one of the world's premier alternative asset managers raising and deploying capital across private equity, credit, and real assets at global scale, while CME Group operates the world's largest ...
Why It’s Moving

Analysts pivot KKR forecast upward as financial services sector momentum and valuation gaps drive 73% upside potential
- Consensus analyst ratings remain a 'Strong Buy' with 10 buy ratings and zero hold or sell ratings, reflecting broad confidence in the firm's long-term trajectory.
- Multiple valuation models project mid-case targets near $195 by late 2030, implying over 100% total return and signaling deep undervaluation at current prices around $94–$97.
- The average 12-month price target sits between $125 and $157 across different analyst groups, with upside ranging from 25% to nearly 60% depending on the baseline price used.

CME Stock Tumbles as Analysts Warn of 11% Downside Amid Tech Sector Profit-Taking and Volatility Fears
- Tech sector investors pulled back on Nasdaq-100 futures, triggering a ripple effect that hit CME's equity options and contributed to the stock's 52-week low breach.
- Erste Group downgraded CME to a 'Hold' rating, citing volatility concerns that overshadow the company's strong market position and consistent dividend history.
- Wall Street analysts note a neutral consensus on CME, with prediction models suggesting potential downside risk despite previous bullish forecasts of $316 in the next 12 months.

Analysts pivot KKR forecast upward as financial services sector momentum and valuation gaps drive 73% upside potential
- Consensus analyst ratings remain a 'Strong Buy' with 10 buy ratings and zero hold or sell ratings, reflecting broad confidence in the firm's long-term trajectory.
- Multiple valuation models project mid-case targets near $195 by late 2030, implying over 100% total return and signaling deep undervaluation at current prices around $94–$97.
- The average 12-month price target sits between $125 and $157 across different analyst groups, with upside ranging from 25% to nearly 60% depending on the baseline price used.

CME Stock Tumbles as Analysts Warn of 11% Downside Amid Tech Sector Profit-Taking and Volatility Fears
- Tech sector investors pulled back on Nasdaq-100 futures, triggering a ripple effect that hit CME's equity options and contributed to the stock's 52-week low breach.
- Erste Group downgraded CME to a 'Hold' rating, citing volatility concerns that overshadow the company's strong market position and consistent dividend history.
- Wall Street analysts note a neutral consensus on CME, with prediction models suggesting potential downside risk despite previous bullish forecasts of $316 in the next 12 months.
Investment Analysis

KKR
KKR
Pros
- KKR reported strong Q3 2025 earnings, exceeding both EPS and revenue forecasts with robust growth in fee-related earnings.
- The firm achieved record fundraising and expanded its presence in high-growth areas such as private credit and Asian markets.
- KKR's acquisition of OSTTRA enhances its infrastructure and technology offerings, broadening its alternative asset management platform.
Considerations
- Despite strong results, KKR's stock has shown volatility and underperformed in pre-market trading, reflecting investor caution.
- The company trades at a high valuation multiple, which may limit upside and increase sensitivity to market sentiment.
- KKR's earnings are closely tied to fundraising cycles and capital markets activity, making them vulnerable to economic downturns.

CME Group
CME
Pros
- CME Group maintains a dominant position in global derivatives trading, benefiting from high trading volumes and market resilience.
- The company generates stable, recurring revenue from clearing and exchange fees, supporting strong cash flow generation.
- CME Group has a robust balance sheet and a history of returning capital to shareholders through dividends and buybacks.
Considerations
- CME Group's growth is limited by market saturation and regulatory scrutiny in the exchange sector.
- Revenue is sensitive to interest rate changes and macroeconomic conditions, which can impact trading activity.
- The company faces increasing competition from alternative trading platforms and fintech disruptors.
KKR (KKR) Next Earnings Date
Based on historical patterns and current projections, KKR & Co. Inc. is estimated to release its next earnings report on July 30, 2026. This upcoming announcement will cover the company's financial results for the second quarter of 2026 (Q2 2026). While the company has not officially confirmed a specific date, analysts typically expect the release within the window of July 29 to July 31, 2026. This briefing provides the scheduled timeline for the earnings release without offering any investment recommendations or price targets.
CME Group (CME) Next Earnings Date
The next earnings date for CME Group (CME) stock is expected on July 22, 2026, based on the company's historical reporting schedule. This upcoming report will cover the second quarter of 2026 (Q2 2026) financial results. While the company has not yet officially confirmed this date, past patterns strongly indicate this timing for the quarterly release. Investors should monitor official company announcements for any potential adjustments to this projected schedule.
KKR (KKR) Next Earnings Date
Based on historical patterns and current projections, KKR & Co. Inc. is estimated to release its next earnings report on July 30, 2026. This upcoming announcement will cover the company's financial results for the second quarter of 2026 (Q2 2026). While the company has not officially confirmed a specific date, analysts typically expect the release within the window of July 29 to July 31, 2026. This briefing provides the scheduled timeline for the earnings release without offering any investment recommendations or price targets.
CME Group (CME) Next Earnings Date
The next earnings date for CME Group (CME) stock is expected on July 22, 2026, based on the company's historical reporting schedule. This upcoming report will cover the second quarter of 2026 (Q2 2026) financial results. While the company has not yet officially confirmed this date, past patterns strongly indicate this timing for the quarterly release. Investors should monitor official company announcements for any potential adjustments to this projected schedule.
Buy KKR or CME in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


